Repair Biotechnologies is a preclinical biotechnology company focused on developing drugs for cholesterol and aging-related diseases. Our first-in-class Cholesterol Degrading Platform (CDP) technology is aimed at reversing atherosclerosis, familial hypercholesterolemias, and other conditions in which excess or modified cholesterol drives pathology.



Repair Biotechnologies, Inc. announced it raised $75,000 in an initial filing from an offering of $75,000

Company Information

Related People

Funding Insights

Repair Biotechnologies, Inc. announced it raised $75,000 in an initial filing from an offering of $75,000

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information